A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature.

@article{Simbar2007ACS,
  title={A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature.},
  author={Masoumeh Simbar and Fahimeh Ramezani Tehrani and Zeinab Hashemi and Hananeh Zham and Ian Stewart Fraser},
  journal={The journal of family planning and reproductive health care},
  year={2007},
  volume={33 4},
  pages={271-6}
}
OBJECTIVES The most common reason for discontinuation of long-acting progestogen-only contraceptives is irregular bleeding following local endometrial vascular changes. To reduce unpredictable bleeding episodes among depot medroxyprogesterone acetate (DMPA) users, the combined injectable contraceptive, Cyclofem, was offered as an alternative. However, there is a gap in our knowledge about the effects of Cyclofem on the endometrial vasculature and patterns of bleeding. This study aimed to… CONTINUE READING